Fiona has 20 years experience in the pharmaceutical industry, 12 of which have been in leadership roles within the peri/post approval space. For the past 4 years, Fiona has led the Cardiovascular and Metabolic IIIb/IV franchise of work. In this role, she provides direction and management to oversight directors assigned to franchise projects and directs and supports global cross-functional Medical Affairs project teams in meeting and exceeding client expectations.
Fiona joined in late 2009 from another large CRO, where she worked as a Business Manager/Project Director focusing on peri/post approval proposal development and oversight of large peri/post approval studies. Prior to this, Fiona had responsibility for the UK and Italian per/post approval project and clinical management teams at a medium size CRO, with her own financial P&L. Under her leadership, the department grew from approximately 10 to 40 individuals with significant increase in revenues. Fiona started her career as a clinical trials coordinator in diagnostics with a J&J company in 1997, moving to project management in 2000 with a medium size CRO.
Throughout her career, Fiona and her teams have been responsible for the delivery of pan-European and global clinical research programs in accordance with ICH-GCP and other applicable guidelines across a variety of different therapeutic areas including Cardiovascular, Dental, Dermatology, Device, Endocrinology/Metabolic, Genitourinary, GI, Infectious Disease, Nervous System, Oncology, Renal and Respiratory as well as experience in Medical Device, Paediatric and OTC compound studies. Fiona has a masters degree in medical biochemistry.